help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Au, D. H.
Right arrow Articles by Bryson, C. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Au, D. H.
Right arrow Articles by Bryson, C. L.
American Journal of Respiratory and Critical Care Medicine Vol 176. pp. 625, (2007)
© 2007 American Thoracic Society


Correspondence

A Major Cause of Death in COPD and Risk Factors for Lung Cancer—a Dilemma or a Mistake?

From the Authors:

We appreciate the comments from Dr. Gowani and colleagues on our article (1). There is a robust literature that clearly describes an association between chronic obstructive pulmonary disease (COPD) and an increased risk of lung cancer that is independent of age and tobacco smoke (2, 3), and recent perspectives suggest a potential genetic linkage between these two commonly occurring diseases (4). What needs further elucidation is why the lung injury that results in COPD augments the risk of lung cancer. In addition, based on the current literature, a patient's cause of death is dependent on the severity of lung disease (5). There is little debate that in patients with severe COPD, respiratory failure is a common cause of death. Of the possible 24 million Americans with COPD, however, most will have mild to moderate airflow limitation (6), and the Lung Health Study demonstrated that among these individuals, lung cancer was the most common cause of death (7). Furthermore, the editorial by Miller and Keith (8) recognized the inclusion of adherence in our article as an advantage, allowing better exposure assessment, rather than a shortcoming. Finally, we appreciate Dr. Gowani and colleagues' attention to the fallibility of the peer-review process, for both pointing out an important typographical error and allowing us to highlight that the cohort was followed for a median of 3.8 years.

David H. Au

Veterans Administration Puget Sound Health Care System, Seattle, Washington and University of Washington, Seattle, Washington

Jason W. Chien

Fred Hutchinson Cancer Research Center, Seattle, Washington and University of Washington, Seattle, Washington

Christopher L. Bryson

Veterans Administration Puget Sound Health Care System, Seattle, Washington and University of Washington, Seattle, Washington

FOOTNOTES

Conflict of Interest Statement: D.H.A. received $1,500 for participating in a GlaxoSmithKline-sponsored advisory round table. J.W.C. has no financial relationship with a commercial entity that has an interest in the subject of this manuscript. C.L.B. has no financial relationship with a commercial entity that has an interest in the subject of this manuscript.

REFERENCES

  1. Parimon T, Chien JW, Bryson CL, McDonell MB, Udris EM, Au DH. Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:712–719.[Abstract/Free Full Text]
  2. Tockman MS, Anthonisen NR, Wright EC, Donithan MG. Airways obstruction and the risk for lung cancer. Ann Intern Med 1987;106:512–518.[Abstract/Free Full Text]
  3. Skillrud DM, Offord KP, Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann Intern Med 1986;105:503–507.[CrossRef][Medline]
  4. Schwartz AG, Ruckdeschel JC. Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:16–22.[Abstract/Free Full Text]
  5. Sin DD, Anthonisen NR, Soriano JB, Agusti G. Mortality in COPD: Role of comorbidities. Eur Respir J 2006;28:1245–1257.[Abstract/Free Full Text]
  6. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance—United States, 1971–2000. MMWR Surveill Summ 2002;51:1–16.[Medline]
  7. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 142:233–239.
  8. Miller YE, Keith RL. Inhaled corticosteroids and lung cancer chemoprevention [editorial]. Am J Respir Crit Care Med 2007;175:636–637.[Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Au, D. H.
Right arrow Articles by Bryson, C. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Au, D. H.
Right arrow Articles by Bryson, C. L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2007 American Thoracic Society